staurosporine has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flajolet, M; Greengard, P; Meijer, L | 1 |
| D'Adamo, P; Ghezzi, D; Invernizzi, F; Lamperti, C; Mora, M; Novara, F; Sevrioukova, I; Uziel, G; Zeviani, M; Zuffardi, O | 1 |
1 review(s) available for staurosporine and Nervous System Diseases
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
1 other study(ies) available for staurosporine and Nervous System Diseases
| Article | Year |
|---|---|
Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor.
Topics: Apoptosis; Apoptosis Inducing Factor; Caspase 3; Computer Simulation; Dietary Supplements; DNA Primers; DNA, Mitochondrial; Electron Transport; Female; Fibroblasts; Flavin-Adenine Dinucleotide; Genes, X-Linked; Humans; In Situ Nick-End Labeling; Infant, Newborn; Magnetic Resonance Imaging; Male; Mitochondrial Encephalomyopathies; Muscle, Skeletal; Mutation; Nervous System Diseases; Pedigree; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Conformation; Riboflavin; Staurosporine; Twins, Monozygotic | 2010 |